Quantitative analysis of effect of topical tafluprost on ocular blood flow in normal subjects

Quantitative analysis of effect of topical tafluprost on ocular blood flow in normal subjects - Tafluprost and ocular blood flow

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004818

Enrollment

Registered

2012-04-01

Start date

2011-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

normal subjects

Interventions

Unilateral eyes with topical tafluprost instillation (unilateral) Contralateral eyes without drug instillation

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Normal subjects not falling under the exclusion criteria

Exclusion criteria

Exclusion criteria: History or presence of systemic diseases that could affect general circulation including hyper tension, cardiac diseases, diabetes mellitus, or arterial sclerosis. History or presence of ocular diseases that could affect measurement of ocular blood flow including cataract, diabetic retinopathy/maculopathy, age-related macular degeneration, glaucoma and optic nerve or retinal abnormality. History of intraocular or refractive surgery. Habitual smoking, pregnancy, or lactation. Those judged to be inappropriate for the participation by the responsible researchers.

Design outcomes

Primary

Measure	Time frame
Quantitative index of blood velocity in ocular tissues obtained with laser speckle method	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026